Lyra Influenza A+B Assay
K-Number: K230236 · 2023-03-03
Device Summary
Frequently Asked Questions
What is the Lyra Influenza A+B Assay?
Lyra Influenza A+B Assay is a medical device that received FDA 510(k) clearance on 2023-03-03. The listed applicant is Quidel Corporation. The 510(k) number is K230236.
When did Lyra Influenza A+B Assay receive FDA 510(k) clearance?
Lyra Influenza A+B Assay received FDA 510(k) clearance on 2023-03-03, under 510(k) number K230236.
Who is the listed applicant for Lyra Influenza A+B Assay?
The FDA 510(k) record lists Quidel Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Lyra Influenza A+B Assay?
The FDA product code for Lyra Influenza A+B Assay is OZE.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Quidel Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: OZE)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.